CMS To Remove Quality Measures For Breast Cancer Biopsies, Some CABG Procedures And More
Executive Summary
As part of its proposed 2019 physician fee schedule and Quality Payment Program, the US Medicare agency plans to remove certain quality measures, including for some coronary artery bypass grafts and pre-operative breast cancer biopsies that medical societies advised providers no longer need to report as QPP Merit-Based Incentive Payment program measures.